Thursday, April 25, 2024
ADVT 
Health

Safe injection sites may curb opioid deaths, report suggests

Darpan News Desk The Canadian Press, 08 Jul, 2020 09:05 PM
  • Safe injection sites may curb opioid deaths, report suggests

A safe haven in the U.S. where people can give themselves heroin and other drugs has observed more than 10,500 injections over five years and treated 33 overdoses with none proving fatal, researchers reported Wednesday.

The injection site is unsanctioned and its location hasn’t been revealed. The researchers say the results, published in the New England Journal of Medicine, show the potential for such places to curb deaths from the opioid epidemic.

Every year in the United States, nearly 70,000 people die of a drug overdose. Quick treatment with the medicine naloxone can prevent death in many cases. Besides offering trained staff to administer it, these injection sites offer safe disposal of used needles and a chance to get users into counselling and help with other health problems.

At least a dozen countries including Canada and many in Europe offer such sites. U.S. cities including Seattle, Boston and Philadelphia have been debating allowing them.

The unofficial one described in the medical journal opened in September 2014. Alex Kral, a San Francisco-based researcher with the research organization RTI International, and Peter Davidson, a medical sociologist at the University of Southern California, San Diego, reported on its five-year results.

As a condition of doing research there, they agreed to keep secret the location of the site and the name of the social service agency that runs it.

They previously described it as having two rooms, one with stainless steel stations that are cleaned and another next door where staff can monitor users afterward. The users bring their own drugs.

MORE Health ARTICLES

Health panel may open lung cancer screening to more smokers

Health panel may open lung cancer screening to more smokers
A U.S. health panel wants to widen the number of Americans offered yearly scans for lung cancer by opening the screening to less-heavy smokers.

Health panel may open lung cancer screening to more smokers

Health care workers at risk of PTSD from COVID: guide

Health care workers at risk of PTSD from COVID: guide
The Centre of Excellence on Post-Traumatic Stress Disorder says health-care workers on the front lines of the COVID-19 pandemic are susceptible to severe stress that could cause long-term psychological damage.

Health care workers at risk of PTSD from COVID: guide

Doctors say experimental treatment may have rid man of HIV

Doctors say experimental treatment may have rid man of HIV
A Brazilian man infected with the AIDS virus has shown no sign of it for more than a year since he stopped HIV medicines after an intense experimental drug therapy aimed at purging hidden, dormant virus from his body, doctors reported Tuesday.

Doctors say experimental treatment may have rid man of HIV

AIDS report: Kids are lagging and COVID-19 is harming care

AIDS report: Kids are lagging and COVID-19 is harming care
New numbers on the global AIDS epidemic show some big successes, such as fewer deaths and new infections. But there are also some tragic failures: Only half the children with HIV, the virus that causes the disease, are getting treatment.

AIDS report: Kids are lagging and COVID-19 is harming care

Dr.Bal Pawa shares information on how to tackle mental health challenges amidst COVID-19

Dr.Bal Pawa shares information on how to tackle mental health challenges amidst COVID-19
Dr. Bal Pawa is a uniquely qualified pharmacist and medical doctor. The combined knowledge, plus 3 decades of clinical experience have fuelled her passion to change the way medical care is delivered

Dr.Bal Pawa shares information on how to tackle mental health challenges amidst COVID-19

Gilead's $2,340 price for coronavirus drug draws criticism

Gilead's $2,340 price for coronavirus drug draws criticism
The maker of a drug shown to shorten recovery time for severely ill COVID-19 patients says it will charge $2,340 for a typical treatment course for people covered by government health programs in the United States and other developed countries.

Gilead's $2,340 price for coronavirus drug draws criticism

PrevNext